News Tags :
cancer
study
fda
glaxosmithkline
breast
recurrence
radiation
tamoxifen
gene
tykerb
diagnosis
saliva
estrogen
alpha
tissue
mechanism

Dense Tissue Promotes Aggressive Cancers

Dense Tissue Promotes Aggressive Cancers

   New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue.

Posted : Sat, Aug 23, 2008

Category : Science / Health News

Breast Cancer: Unlocking Mechanisms That Silence Estrogen Receptor Gene Alpha

Breast Cancer: Unlocking Mechanisms That Silence Estrogen Receptor Gene Alpha

   The mechanisms that silence the estrogen receptor gene alpha (ER-α) in certain breast cancer cell lines may be closer to being unlocked, according to a study by researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine.

Posted : Sat, Aug 18, 2007

Category : Science / Health News

Penn Researchers Home In On Possible New Breast Cancer Gene

Penn Researchers Home In On Possible New Breast Cancer Gene

   Researchers at the Abramson Family Cancer Research Institute of the University of Pennsylvania and the Dana-Farber Cancer Institute describe in this week's issue of Science a new candidate breast-cancer susceptibility gene. The Rap80 gene is required for the normal DNA-repair function of the well-known breast cancer gene BRCA1.

Posted : Mon, May 28, 2007

Category : Science / Health News

Saliva Test For Breast Cancer Diagnosis

Saliva Test For Breast Cancer Diagnosis

   A new study found that the protein levels in saliva have great potential to assist in the diagnosis, treatment, and follow-up care of breast cancer. The general dentists are perfect candidates to assist with this diagnosis samples because they can easily remove saliva samples from a patient's mouth during routine visits.

Posted : Tue, Mar 20, 2007

Category : Science / Health News

Tykerb Approved Treatment Of Breast Cancer

Tykerb Approved Treatment Of Breast Cancer

   On Wednesday, British drug maker GlaxoSmithKline PLC announced today that the United States Food and Drug Administration (FDA) approved its breast cancer treatment Tykerb to be used with Roche Holding's Xeloda in patients with advanced breast cancer or breast cancer that has spread to other parts of the body.

Posted : Wed, Mar 14, 2007

Category : Science / Health News

Radiation after breast cancer reduces cancer recurrence

Radiation after breast cancer reduces cancer recurrence

   Researchers from Wake Forest University School of Medicine reported that radiation therapy afterlumpectomy and five years of treatment with the drug tamoxifen can dramatically reduce the risk of both cancer recurrence and new tumors in older women with early breast cancer.

Posted : Mon, Jan 22, 2007

Category : Science / Health News
 
 
 
© TAUME.COM